Point72 Middle East FZE’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,210
Closed -$181K 444
2023
Q4
$181K Buy
17,210
+11,991
+230% +$107K 0.01% 1071
2023
Q3
$47.7K Buy
+5,219
New +$46.8K ﹤0.01% 1239
2023
Q2
Sell
-197
Closed -$1.67K 1689
2023
Q1
$1.67K Sell
197
-5,047
-96% -$45.6K ﹤0.01% 1546
2022
Q4
$39.4K Buy
+5,244
New +$40.6K ﹤0.01% 1506

Other funds holding EOLS

Point72 Middle East FZE's EOLS Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Evolus (EOLS) in Q1 2024, closing a stake of 17,210 shares — an estimated $181K sold.

Point72 Middle East FZE first reported a position in EOLS in Q4 2022 and held it in 4 quarters. The position peaked at $181K in Q4 2023. 164 funds tracked by Wall St. Rank hold EOLS as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Evolus position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 17,210 Evolus shares in Q1 2024, an estimated $181K.
  • Point72 Middle East FZE first reported a position in Evolus in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Evolus position peaked at $181K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Evolus as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.